VI-RADS score system - A primer for urologists
International Braz J Urol, ISSN: 1677-6119, Vol: 48, Issue: 4, Page: 609-622
2022
- 13Citations
- 20Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations13
- Citation Indexes13
- 13
- CrossRef8
- Captures20
- Readers20
- 20
Article Description
Bladder cancer (BCa) is one of the most common cancers worldwide and is also considered to be one of the most relapsing and aggressive neoplasms. About 30% of patients will present with muscle invasive disease, which is associated with a higher risk for metastatic disease. The aim of this article is to review the state of art imaging in Radiology, while providing a complete guide to urologists, with case examples, for the rationale of the development of the Vesical Imaging Reporting and Data System (VI-RADS), a scoring system emphasizing a standardized approach to multiparametric Magnetic Resonance Imaging (mpMRI) acquisition, interpretation, and reporting for BCa. Also, we examine relevant external validation studies and the consolidated literature of mpMRI for bladder cancer. In addition, this article discusses some of the potential clinical implications of this scoring system for disease management and follow-up
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85130862051&origin=inward; http://dx.doi.org/10.1590/s1677-5538.ibju.2021.0560; http://www.ncbi.nlm.nih.gov/pubmed/35195385; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000400609&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000400609&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S1677-55382022000400609&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000400609; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S1677-55382022000400609; https://dx.doi.org/10.1590/s1677-5538.ibju.2021.0560; https://www.scielo.br/j/ibju/a/85MpH6dHhCmvGDq4GGpttsD/?lang=en
FapUNIFESP (SciELO)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know